Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 15,302 | 16,136 | 23,790 | 27,430 | 33,744 |
| Operating Income | -15,302 | -16,136 | -23,790 | -27,430 | -33,744 |
| Interest Expense | 158 | 33 | 0 | 49 | 69 |
| Other Income | -11,496 | 1,254 | 5,559 | 775 | -125 |
| Pre-tax Income | -26,957 | -14,916 | -18,231 | -26,704 | -33,938 |
| Net Income Continuous | -26,957 | -14,916 | -18,231 | -26,704 | -33,938 |
| Net Income Discontinuous | N/A | N/A | N/A | 3,097 | -1,348 |
| Minority Interests | -782 | -713 | -328 | N/A | N/A |
| Net Income | $-26,175 | $-14,203 | $-17,902 | $-23,607 | $-35,285 |
| EPS Basic Total Ops | -8.20 | -13.12 | -29.93 | -39.61 | -65.58 |
| EPS Basic Continuous Ops | -8.20 | -13.12 | -29.94 | -44.77 | -63.06 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 5.19 | -2.50 |
| EPS Diluted Total Ops | -8.20 | -13.12 | -29.93 | -39.61 | -65.58 |
| EPS Diluted Continuous Ops | -8.20 | -13.12 | -29.94 | -44.77 | -63.06 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 5.19 | -2.50 |
| EPS Diluted Before Non-Recurring Items | -8.20 | -13.12 | -29.87 | -44.81 | -62.99 |
| EBITDA(a) | $-14,757 | $-15,646 | $-21,283 | $-22,895 | $-29,698 |